[T3 toxicosis].
Iwatani
Yoshinori
Y
Department of Biomedical Informatics, Division of Health Science, Osaka University Graduate School of Medicine.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006044:Goiter, Nodular / Q000150:complications; D006111:Graves Disease / Q000150:complications; D006801:Humans; D011379:Prognosis; D011433:Propranolol / Q000627:therapeutic use; D011441:Propylthiouracil / Q000627:therapeutic use; D013971:Thyrotoxicosis / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D014284:Triiodothyronine / Q000378:metabolism*
D000319:Adrenergic beta-Antagonists; D013956:Antithyroid Agents; D014284:Triiodothyronine; D011441:Propylthiouracil; D011433:Propranolol